Content Currently Unavailable
Article | 2025 American Academy of Ophthalmology Annual Meeting
Tiespectus Improves Vision and Retinal Thickness in BRVO
Part one of the RIOJA trial reports no serious adverse events or dose-limiting toxicity.
Content Currently Unavailable







